Breaking News Instant updates and real-time market news.

MA

MasterCard

$127.43

0.42 (0.33%)

07:33
07/18/17
07/18
07:33
07/18/17
07:33

MasterCard price target raised to $133 from $125 at Oppenheimer

Oppenheimer analyst Glenn Greene raised his price target for MasterCard to $133 from $125 ahead of Q2 results as he is encouraged by "solid" April intra-quarter volume growth, "solid" retail sales growth, broadly positive car-issuer volumes and improving FX trends. The analyst reiterates an Outperform rating on the shares.

  • 07

    Sep

MA MasterCard
$127.43

0.42 (0.33%)

05/03/17
OPCO
05/03/17
NO CHANGE
Target $125
OPCO
Outperform
MasterCard price target raised to $125 from $120 at Oppenheimer
Oppenheimer analyst Glenn Greene raised his price target for MasterCard to $125 from $120 after the company delivered "solid upside Q1 results." The analyst is encouraged by recent strong revenue/volume growth and believes the company's longer term growth trajectory remains intact. He reiterates an Outperform rating on the shares.
06/27/17
MZHO
06/27/17
INITIATION
Target $125
MZHO
Neutral
MasterCard initiated with a Neutral at Mizuho
Mizuho analyst Thomas McCrohan initiated MasterCard with a Neutral and a $125 price target.
07/10/17
DBAB
07/10/17
NO CHANGE
Target $122
DBAB
Buy
Deutsche Bank raises price targets for Visa, MasterCard
Deutsche Bank analyst Bryan Keane raised his price target for Visa (V) to $122 from $103 and for MasterCard (MA) to $150 from $124. The analyst believes push payments have the potential to contribute an incremental 5% to net revenue growth for both companies over the next five years and help drive 20%-plus annual earnings growth. He reiterates Buy ratings on both stocks with a preference for Visa over MasterCard. Push payments, also known as buyer-initiated payments or straight through processing, "ride the network rails and hence offer all the benefits of card payments with more security as the payer pushes funds instead of the payee pulling funds from an account," Keane explains.
07/14/17
PIPR
07/14/17
NO CHANGE
Target $54
PIPR
Neutral
PayPal price target raised to $54 from $45 at Piper Jaffray
Piper Jaffray analyst Jason Deleeuw raised his price target for PayPal (PYPL) to $54 saying easing currency headwinds will complement "continued solid" U.S. and international digital payment volume trends. The bar for the company's Q2 results has been raised given PayPal's "significant short-term share outperformance and premium valuation" to Visa (V) and MasterCard (MA), Deleeuw tells investors in a research note. The analyst keeps a Neutral rating on PayPal citing long-term competitive risks.

TODAY'S FREE FLY STORIES

XLB

S&P Select Materials SPDR

$58.24

0.22 (0.38%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.82

0.57 (1.05%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.03

-0.29 (-0.53%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.03

-1.06 (-4.22%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Recommendations
Skechers analyst commentary  »

Evercore ISI initiates a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.79

0.51 (0.61%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$149.29

-0.23 (-0.15%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$15.16

5.69 (60.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Technical View: uniQure hits fresh 52-week highs, levels to watch »

The stock is up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$231.47

0.19 (0.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$255.79

0.07 (0.03%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.33

0.02 (0.08%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$97.85

-0.2 (-0.20%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$148.31

-0.55 (-0.37%)

08:16
10/20/17
10/20
08:16
10/20/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
10/20/17
10/20
08:16
10/20/17
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$6,092.62

-21.73589 (-0.36%)

08:16
10/20/17
10/20
08:16
10/20/17
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
10/20/17
10/20
08:15
10/20/17
08:15
General news
Canada retail sales preview »

Canada retail sales…

TSM

TSMC

$41.07

-0.43 (-1.04%)

08:14
10/20/17
10/20
08:14
10/20/17
08:14
Periodicals
TSMC raises IC market forecast for 2017, DigiTimes reports »

Taiwan Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.71

-8.25 (-12.14%)

08:14
10/20/17
10/20
08:14
10/20/17
08:14
Recommendations
United Continental analyst commentary  »

United Continental lack…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$157.16

0.31 (0.20%)

08:13
10/20/17
10/20
08:13
10/20/17
08:13
Initiation
Stanley Black & Decker initiated  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ENTA

Enanta

$47.40

0.1 (0.21%)

08:09
10/20/17
10/20
08:09
10/20/17
08:09
Hot Stocks
Enanta to present preclinical data on EDP-305 at The Liver Meeting »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 06

    Nov

DQ

Daqo New Energy

$32.70

1.01 (3.19%)

08:08
10/20/17
10/20
08:08
10/20/17
08:08
Recommendations
Daqo New Energy analyst commentary  »

Daqo New Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNTX

Gentex

$20.66

0.2 (0.98%)

08:07
10/20/17
10/20
08:07
10/20/17
08:07
Earnings
Gentex reports Q3 EPS 31c, consensus 31c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

GILD

Gilead

$81.59

1.58 (1.97%)

08:06
10/20/17
10/20
08:06
10/20/17
08:06
Hot Stocks
Gilead says study results add to evidence supporting viral hepatitis therapies »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 26

    Oct

  • 06

    Nov

  • 12

    Feb

CELG

Celgene

$135.96

-1.21 (-0.88%)

08:06
10/20/17
10/20
08:06
10/20/17
08:06
Technical Analysis
Technical View: Celgene falls after discontinuing GED-0301 phase III trial »

The stock is down over 6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

PRTA

Prothena

$58.53

-1.83 (-3.03%)

08:05
10/20/17
10/20
08:05
10/20/17
08:05
Conference/Events
Prothena management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 06

    Nov

AUPH

Aurinia Pharmaceuticals

$6.46

-0.05 (-0.77%)

08:05
10/20/17
10/20
08:05
10/20/17
08:05
Hot Stocks
Aurinia Pharmaceuticals to expand retail franchise with novel indications »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.